Kyverna Therapeutics, Inc.
KYTX
$9.40
$0.040.43%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -2.35% | -46.78% | -38.86% | -34.38% | 396.98% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 57.94% | 0.00% | 2.47% | -12.15% | 48.09% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -2.63% | -46.24% | -38.56% | -34.05% | 379.03% |
|
|
|||||
| Total Current Assets | -2.63% | -46.24% | -38.56% | -34.05% | 379.03% |
| Net Property, Plant & Equipment | -49.15% | -44.46% | -39.41% | -30.97% | 0.43% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 60.98% | 142.17% | 157.64% | 140.88% | -13.59% |
| Total Assets | -3.55% | -44.82% | -37.62% | -33.16% | 305.14% |
|
|
|||||
| Total Accounts Payable | 14.75% | -69.63% | 104.01% | 13.70% | 6.10% |
| Total Accrued Expenses | 8.02% | 58.68% | 78.31% | 98.53% | 178.00% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.74% | -6.26% | -7.60% | -3.58% | 34.93% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 8.09% | 9.31% | 69.47% | 52.26% | 69.98% |
|
|
|||||
| Total Current Liabilities | 8.09% | 9.31% | 69.47% | 52.26% | 69.98% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -92.56% | -74.27% | -61.79% | -52.96% | -30.15% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 61.73% | -3.50% | 42.30% | 26.39% | 46.28% |
|
|
|||||
| Common Stock & APIC | 23.96% | 1.96% | 1.82% | 1.61% | 11,317.54% |
| Retained Earnings | -61.21% | -71.23% | -82.85% | -89.36% | -93.70% |
| Treasury Stock & Other | -7.62% | -81.05% | 45.95% | 0.00% | 2,525.00% |
| Total Common Equity | -12.87% | -49.80% | -44.72% | -37.95% | 302.89% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -12.87% | -49.80% | -44.72% | -37.95% | 302.89% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -12.87% | -49.80% | -44.72% | -37.95% | 442.10% |
|
|
|||||